
Shockingly study reveals olive oil contributes to obesity
It's time for an oil change, really. A recent study has stunned people with the news that olive oil actually contributes to obesity.
For years, olive oil has been consumed as a healthy alternative to other cooking oils. According to the North American Olive Oil Association, more than
50%
of American households use olive oil due to its flavour and health benefits. According to a
study
published in the National Library of Medicine, olive oil has anti-inflammatory, hepatoprotective, renoprotective and anti-neurodegenerative agents.
However, a recent study published in the journal Cell Reports revealed that eating a high-fat diet containing a huge amount of oleic acid- a type of fatty acid found in olive oil, can cause more obesity than other types of dietary fats.
Oleic acid, a monosaturated fat associated with obesity, leads the body to make more fat cells. High levels of the acid boost a signalling protein, AKT2 and reduce the activity of a regulating protein LXR, to result in the faster growth of the precursor cells that form new fat cells.
"We know that the types of fat that people eat have changed during the obesity epidemic. We wanted to know whether simply overeating a diet rich in fat causes obesity, or whether the composition of these fatty acids that make up the oils in the diet is important. Do specific fat molecules trigger responses in the cells?" said Michael Rudolph, Ph.D, assistant professor of biochemistry and physiology at the University of Oklahoma College of Medicine and member of OU Health Harold Hamm Diabetes Center to Medical Xpress.
The shocking research
Image credits: Getty Images
Rudolph and his team which included other collaborators at Yale University School of Medicine and New York University School of Medicine, carried out the research by feeding mice a variety of specialized diets rich in particular individual fatty acids, including those found in coconut oil, peanut oil, milk, lard and soybean oil.
Oleic acid was the only one that led to precursor cells that gave rise to fat cells to proliferate more than other fatty acids.
"You can think of the fat cells as an army," explained Rudolph. "When you give oleic acid, it initially increases the number of 'fat cell soldiers' in the army, which creates a larger capacity to store excess dietary nutrients. Over time, if the excess nutrients overtake the number of fat cells, obesity can occur, which can then lead to cardiovascular disease or diabetes if not controlled."
He suggested consuming fats in moderation and from a variety of sources. "Relatively balanced levels of oleic acid seem to be beneficial, but higher and prolonged levels may be detrimental. If someone is at risk for heart disease, high levels of oleic acid may not be a good idea."
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
an hour ago
- Hindustan Times
Deion Sanders stepping down amid health struggles? Colorado's 'Prime Time' faces questions ahead of press conference
Colorado head coach and Hall of Fame cornerback Deion Sanders is going to address the public in a press conference on Monday, July 18, and is expected to provide some clarity on his health. While no one knows what Sanders is going to reveal, netizens have speculated that he may be stepping down for health-related reasons. Deion Sanders stepping down amid health struggles? Colorado's 'Prime Time' faces questions ahead of press conference (Photo by Stacy Revere / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)(Getty Images via AFP) 'He's stepping down for medical reasons is my guess,' one user wrote on Reddit. 'It's not a good sign when the medical team is involved in the conference,' another said. 'Hope it's not serious, whatever it is. He's brought a lot of excitement to Colorado, I'd hate to see him have to step down for medical reasons,' one user wrote, while another said, 'I hope he's not stepping down. I might be in the minority, but I love Coach Prime. Brings so much excitement to a program that was down bad. Either he lost and I laughed at him. Or he lost and I laughed at his haters.' 'The last photo of him with the bucs coach he looked noticeably thinner. Hope all is ok for Prime,' wrote one user. Another said, 'Tf this seems out of nowhere? Hope it's nothing terrible and it's a quick recovery for him.' Deion Sanders' press conference Sanders is expected to appear for the press conference alongside his medical team. This comes after days of speculations about his health. In a video posted July 20 by Deion Jr., Sanders said he was still "going through something" and has yet to completely recover, Due to his unspecified health issues, Sanders' participation has been limited over the spring and summer. However, he said earlier this month at Big 12 Media Days that he is back to getting to work on the upcoming season. "I'm already back," Sanders said at the time. "I'm here today. I'm handling my responsibilities. So, I look forward to it. I can't wait. You've got to understand, some of the young [players] I haven't even met yet. I'm so excited about that."


Time of India
2 hours ago
- Time of India
Prostate cancer: 7 myths that can delay cancer diagnosis in men
When it comes to men's health, prostate cancer tends to fly under the radar—until it doesn't. Prostate cancer is one of the most common cancers in American men, second only to skin cancer. And yet, myths and misunderstandings still cloud how we talk about it, test for it, and treat it. From the idea that it only affects "older guys" to the belief that early signs of prostate cancer always come with obvious symptoms (spoiler: they usually don't), misinformation can be dangerous. Worse, it often leads to delays in diagnosis and prostate cancer treatment—and time matters when dealing with any cancer. Whether you're in your 40s or your 70s, knowing the facts about prostate health is just smart self-care. What is Prostate Cancer? Prostate cancer starts in the prostate gland, a small, walnut-sized part of the male reproductive system that sits just below the bladder. But sometimes, the cells in the prostate start growing out of control. That's when cancer kicks in. The tricky part is that prostate cancer symptoms often don't show up early. Most guys feel totally fine, no pain, no warning signs, nothing. That's why regular prostate cancer screening, including PSA tests and yes, the digital rectal exam, matter. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Indonesia: Unsold Sofas Prices May Surprise You (Prices May Surprise You) Sofas | Search Ads Search Now Undo In many cases, prostate cancer is highly treatable, especially when caught early. But if left undetected, it can spread to bones, lymph nodes, and other areas. That's why keeping tabs on your prostate health, especially after age 50, is a game-changer. Think of it as part of long-term men's cancer awareness—your future self will thank you. Myth: 'If I don't have symptoms, I don't have prostate cancer.' Sorry, wish it were true! The sneaky thing about prostate cancer is that in the early stages, it usually has no symptoms at all. Nope, not even a twinge or a peep. When symptoms like trouble peeing or back pain do pop up, it usually means the cancer has already advanced. That's why screening and talking to your doc (even when you feel perfectly fine) is so important, especially if you're over 50, African-American, or have a family history of prostate cancer. Myth: 'Only old men get prostate cancer.' Sure, risk increases as you get older—most cases happen in men over 65. But younger men can and do get prostate cancer, sometimes even in their forties or fifties. Bottom line: age is a big risk factor, but it's not a guarantee. No matter your age, be aware of your personal risk and talk it over with your health provider. Myth: 'If my dad had it, I'm doomed.' Having a father (or brother) with prostate cancer definitely bumps up your risk—about double, in fact. But it's not destiny; plenty of men with a strong family history never get prostate cancer. And on the flip side, about 90% of prostate cancers pop up in men with no family history at all. Your family history is important to know, but it's not a crystal ball. Myth: 'Screenings and PSA tests are pointless (or will always lead to unnecessary treatment).' Screening is controversial, but it's not pointless! The PSA (prostate-specific antigen) blood test can catch cancer before symptoms show up, but it's not foolproof. Some cancers are slow, harmless guests; others need action, fast. If you have an elevated PSA, that's just one piece of the puzzle, not an automatic cancer diagnosis or reason to rush into treatment. Decisions should always be personal, based on your age, health, and family history—and in conversation with your doctor. Myth: 'If I have prostate cancer, I need treatment right now.' Not all prostate cancers are aggressive or dangerous. Some are so slow-growing that your doctor may recommend 'active surveillance'—keep an eye on things with regular tests and only step in if the situation changes. For many men, avoiding or delaying treatment means fewer side effects, while still staying safe. Myth: 'Treatments always ruin your sex life and cause incontinence.' Treatments can have side effects, including trouble with erections and urinary issues—you've probably heard this a lot. But not every guy who gets treated ends up with long-term problems. Side effects depend on many factors: your age, the specific treatment, and even the experience of your healthcare team. Plus, treatments and support to help manage side effects are better than ever. Myth: 'If you don't eat sugar or take special vitamins, you won't get prostate cancer.' Let's clear the air: eating sugar doesn't cause prostate cancer, and there's no magic diet or supplement that can prevent it. Obesity is linked to a higher risk of several cancers, including prostate, so eating healthy matters, but skipping sugar or popping vitamins won't give you a get-out-of-cancer card.


The Hindu
3 hours ago
- The Hindu
New microscope reveals molecular jostling faster than ever before
More than a century ago, a 26-year-old Albert Einstein explained Brownian motion in one of four papers he published in his annus mirabilis, the miraculous year, called because these papers shot him to fame. Brownian motion is the random jittering of small particles in a fluid, caused because they're constantly colliding with molecules around them. Now, scientists at the California Institute of Technology (Caltech) have developed a breakthrough imaging technique that enables real-time filming of these molecular motions. Their findings were published in Nature Communications. 'Surreal experience' Conventional microscopes are invasive and have limited fields of view. Other microscopes still can't distinguish individual molecules, which are around tens of angstroms in size (1 angstrom = 0.0000000001 m). To compare, one human hair is about a million angstrom thick. The Caltech team has now found a way to indirectly detect molecules by observing their interactions with light. Their technique also taps into the Brownian motion of particles. Using the device they have reported that they can see down to tens of angstroms. 'It was a surreal experience to visualise molecular sizes in real-time at the angstrom scale,' Yogeshwar Nath Mishra, who co-led the study when at Caltech's Jet Propulsion Laboratory and who is now an assistant professor at IIT-Jodhpur, said. 'Even more remarkable was the realisation that no existing technique can achieve this level of detail.' Need for speed The more massive a particle, the slower its Brownian motion. '[It] is like watching how much a spinning object twists after being nudged by light. Small molecules spin fast and scramble the light more. Big molecules spin slowly and keep it aligned,' Lihong Wang, director of the Caltech Optical Imaging Laboratory and who supervised the study, said. So by measuring how fast a molecule changes the properties of light, they could determine its size. The Egyptian-American chemist Ahmed Zewail from Caltech was the first to measure particle motion at super-short time scales. This work allowed his team to observe chemical reactions as they happened for the first time. He was awarded the Nobel Prize for chemistry in 1999. 'While traditional techniques often rely on time-consuming point-by-point scanning, our approach captures the scene in a single shot,' Wang said. 'We also achieved imaging speeds of hundreds of billions of frames per second, making it possible to observe molecular interactions in unprecedented slow motion.' The device is thus the world's fastest single-shot microscope. 'Finally, unlike [traditional methods] which require extensive sample preparation and often damage the specimen, our method is non-intrusive, enabling direct, in-situ measurements,' Wang added. 'Some of the most exciting features of this microscope include its wide-field imaging capability, offering an image area of a few square centimetres, an order of magnitude larger than conventional microscopes,' per Mishra. 'To the best of our knowledge, our work is the first ever to achieve the feat of single-shot 2D molecular sizing.' Playing jigsaw They tested their microscope using a molecule called fluorescein-dextran. Fluorescein is a food colouring dye. Fluorescein-dextran is used to monitor blood flow, drug delivery, and tissue and cell labelling. These fluorescent molecules come in the form of powders. The scientists blended them with water and used clean pipettes to pour drops of these samples into cuvettes (clear, short, rectangular tubes for holding liquid samples). Then they turned to ultrashort pulses from a laser. These lasers aren't unlike those used in LASIK and cataract surgeries. The laser sheet slices through the sample in the cuvette. As it does, the sample emits light that falls on an array of small square mirrors making up a digital micromirror device (DMD). The DMD's job is to shape the light beam. Researchers use software code to tilt each individual mirror in this light-crafter depending on the corresponding pixel in the input image. 'Imagine you're trying to solve a jigsaw puzzle, but instead of having all the pieces, you only have a few of them — and surprisingly, you can still figure out what the full picture looks like,' Wang said. This idea underpins the team's technique, which can reconstruct the full picture from very few measurements provided the structure is repetitive. The DMD converts the transient scene into a random jigsaw pattern from which researchers can extract information about the full picture. The light finally passes through a streak tube that converts the photons in light to electrons. A phosphor screen collects these electrons as they sweep across it and creates a pattern of streaks. The streak pattern reveals the pulse duration from which scientists can infer the sizes of the molecules. Ensemble of molecules 'It is an interesting piece of work. The key in this work is the use of the streak camera to detect dynamics in nanoseconds. This is within the actual lifetimes of the molecules and wouldn't be possible with slow detectors or photodetectors,' Basudev Roy, an associate professor at IIT Madras who works on super-resolution microscopy and wasn't involved in the recent study, said. The size of molecules measured using their technique concurred with previous estimates. 'It still sees an ensemble of molecules inside a detection region — it still doesn't see a single molecule yet. But the dynamics indicate chemical compositions and also chemical reactions,' Roy said. 'Surprisingly, we found out that the technique also works in gas phases. … Initially, we assumed it would be challenging to apply [it] in turbulent environments, such as within a flame,' said study co-lead Peng Wang of Caltech. The team observed black carbon nanoparticles in flames through the microscope. 'Our data in the gas phase turned out to work excellently and the molecule size matches … experimental observation well,' Peng said. This new imaging technique could help better visualise processes and transform biomedical research, disease detection, drug design, and nanomaterial fabrication, among others. Unnati Ashar is a freelance science journalist.